Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Clinical trial NCT04264442 · TERMINATED
Trial details
- NCT number
- NCT04264442
- Sponsor
- Fulcrum Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2024-11-07
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.